We are live on ! Find out more
HIMS icon

Hims & Hers Health

139 hedge funds and large institutions have $497M invested in Hims & Hers Health in 2022 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 42 increasing their positions, 33 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

162% more call options, than puts

Call options by funds: $6.99M | Put options by funds: $2.66M

27% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 33

26% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 23

5.01% more ownership

Funds ownership: 50.26%55.27% (+5%)

4% more funds holding

Funds holding: 134139 (+5)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

6% less capital invested

Capital invested by funds: $527M → $497M (-$30.3M)

Holders
139
Holders Change
+5
Holders Change %
+3.73%
% of All Funds
2.34%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.13%
New
29
Increased
42
Reduced
33
Closed
23
Calls
$6.99M
Puts
$2.66M
Net Calls
+$4.33M
Net Calls Change
+$288K

HIMS Hedge Fund Activity: Q2 2022 in Review

139 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q2 2022, worth a combined $497M — down 5.8% from $527M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new HIMS positions and 23 closed out — a net gain of 6 holders — while 42 added to existing stakes and 33 trimmed.

The largest buyer was BlackRock, adding an estimated $26.4M. The largest seller was Thrive Capital Management (New York), exiting entirely with an estimated $17.1M sold.

  • 139 institutional investors held Hims & Hers Health (HIMS) as of Q2 2022, up from 134 in Q1 2022.
  • Funds reported $497M of Hims & Hers Health stock for Q2 2022, down 5.8% quarter-over-quarter.
  • 29 funds opened new Hims & Hers Health positions in Q2 2022 and 23 closed out, a net change of +6 holders.
  • The largest Hims & Hers Health buyer in Q2 2022 was BlackRock, an estimated $26.4M added.
  • The largest Hims & Hers Health seller in Q2 2022 was Thrive Capital Management (New York), an estimated $17.1M sold.

Based on aggregated 13F filings for Q2 2022.